0001104659-21-153177.txt : 20211223
0001104659-21-153177.hdr.sgml : 20211223
20211223165207
ACCESSION NUMBER: 0001104659-21-153177
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211214
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Susan Laura
CENTRAL INDEX KEY: 0001901039
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 211517743
MAIL ADDRESS:
STREET 1: 5 OVERLOOK CT
CITY: LAMBERTVILLE
STATE: NJ
ZIP: 08530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
3
1
tm2135463-10_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2021-12-14
1
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001901039
Smith Susan Laura
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK
NY
10169
0
1
0
0
Senior Vice President, CCO
/s/ Susan Laura Smith
2021-12-23